Author:
Crummer Elliott,Cohen Joshua T.,Rosmarin David,Lin Pei-Jung
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Bergqvist C, Ezzedine K (2020) Vitiligo: a review. Dermatology 236(6):571–592. https://doi.org/10.1159/000506103
2. Bhandarkar SS, Kundu RV (2012) Quality-of-life issues in Vitiligo. Dermatol Clin 30(2):255–268. https://doi.org/10.1016/j.det.2011.11.013
3. FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older, U.S. Food & Drug Administration (2022) https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older. Accessed 1 February 2024
4. Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D, Pandya AG (2021) Psychosocial effects of Vitiligo: a systematic literature review. Am J Clin Dermatol 22(6):757–774. https://doi.org/10.1007/s40257-021-00631-6
5. Kussainova A, Kassym L, Akhmetova A, Glushkova N, Sabirov U, Adilgozhina S, Tuleutayeva R, Semenova Y (2020) Vitiligo and anxiety: a systematic review and meta-analysis. PLoS ONE 15(11):e0241445. https://doi.org/10.1371/journal.pone.0241445